Abstract | OBJECTIVE: To investigate the proliferation inhibitory role and mechanism of PI3Kδ inhibitor CAL-101 on multiple myeloma (MM) cells, and to provide new therapeutic options for MM treatment. METHODS: MM cell lines U266 and RPMI8226 cells were treated with various concentrations of CAL-101. MTT assay and CalcuSyn software were performed to determine the inhibitory effect of CAL-101 and the synergistic effect with PCI- 32765, SAHA ( suberoylanilide hydroxamic acid), BTZ ( Bortezomib) on MM cells. The protein expression level of p-AKT, p-ERK, AKT, ERK and PI3Kδ processed by CAL-101 were analyzed by Western blot. RESULTS:
CAL-101 at concentration of 15, 20, 25, 30 and 40 μmol/L could induce significant dose-dependent proliferation inhibition on U266 cells after treatment for 48 hours. The cell proliferation inhibition rates were (33.54 ± 1.23)%, (41.72 ± 1.78)%, (53.67 ± 2.01)%, (68.97 ± 2.11)% and (79.25 ± 1.92)%, respectively. Similar results were found in RPMI8226 cell line. Western blots showed high expression level of p-AKT, p-ERK, AKT, ERK and PI3Kδ in cell lines and MM primary cells. p-AKT and p-ERK protein expression levels were down-regulated significantly by CAL-101 treatment. Synergistic effect has been verified between CAL-101 and PCI-32765, SAHA and Bortezomib in U266 cell line, and PCI-32765, Bortezomib in RPMI8226 cell line with CI values less than 1. CONCLUSION:
CAL-101 could inhibit proliferation of MM cell lines. High levels of p-AKT, p-ERK, AKT, ERK and PI3Kδ protein expression were observed in both cell lines and primary cells. Down-regulation of p-AKT and p-ERK probably related with the mechanism of CAL-101 in MM cell proliferation inhibition. CAL-101 has significant synergistic effect with PCI-32765, SAHA and BTZ.
|
Authors | Qing Zhang, Bing Xia, Fulian Qu, Tian Yuan, Shanqi Guo, Weipeng Zhao, Qian Li, Hongliang Yang, Yafei Wang, Yizhuo Zhang |
Journal | Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
(Zhonghua Xue Ye Xue Za Zhi)
Vol. 35
Issue 10
Pg. 926-30
(Oct 2014)
ISSN: 0253-2727 [Print] China |
PMID | 25339332
(Publication Type: Journal Article)
|
Chemical References |
- Boronic Acids
- Phosphoinositide-3 Kinase Inhibitors
- Piperidines
- Protein Kinase Inhibitors
- Purines
- Pyrazines
- Pyrazoles
- Pyrimidines
- Quinazolinones
- ibrutinib
- Bortezomib
- Adenine
- idelalisib
|
Topics |
- Adenine
(analogs & derivatives)
- Boronic Acids
- Bortezomib
- Cell Line, Tumor
- Cell Proliferation
- Down-Regulation
- Humans
- Multiple Myeloma
(pathology)
- Phosphoinositide-3 Kinase Inhibitors
- Piperidines
- Protein Kinase Inhibitors
(pharmacology)
- Purines
(pharmacology)
- Pyrazines
- Pyrazoles
- Pyrimidines
- Quinazolinones
(pharmacology)
|